Xeris Biopharma Holdings Inc

XERSNASDAQ · USD
9.10USD0.00 (+1.68%)
347

Xeris Biopharma Holdings Inc (XERS) Wheel Strategy

XERS wheel strategy scan is loading cash-secured put setups from the prior session (filters: probability of expiring worthless above 50%, ranked by annualized return)…

Read more

Running a XERS wheel strategy lets you generate consistent premium income on Xeris Biopharma Holdings Inc while setting your own entry and exit prices on the underlying. Xeris Biopharma Holdings Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own XERS, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best XERS wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on XERS, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable XERS wheel from a losing one.

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect.

The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the XERS wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your XERS wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

No illustrative rows to display.

As of September 25, 2026

Run the Wheel on XERS With Confidence

Find the best XERS wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial